Condition
Malaria, Cerebral
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (1)
P 1 (3)
P 2 (1)
P 3 (1)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05478720Phase 1RecruitingPrimary
DON in Pediatric Cerebral Malaria
NCT03300648Phase 3CompletedPrimary
Treating Brain Swelling in Pediatric Cerebral Malaria
NCT00292942Phase 1Completed
Study of the Safety of Intravenous Artesunate
NCT00292929Phase 1Completed
Study of the Safety of Intravenous Artesunate
NCT01388842Phase 2CompletedPrimary
Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
NCT00658450Not ApplicableCompletedPrimary
Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral Malaria
Showing all 6 trials